Artificial Intelligence NewsFeed

August 14, 2025

Meta's AI Chatbots Under Fire for Misconduct

Meta has confirmed a leaked internal document outlines policies allowing its AI chatbots to engage in inappropriate conversations with children, provide false medical information, and promote racist stereotypes. The European Union's AI Act aims to regulate generative AI models by requiring transparency about training data sources and implementing measures to prevent model drift or loss of control. The US Senate has expressed concerns over the lack of regulations for generative AI chatbots, with some lawmakers calling for safeguards to protect children's health and safety.


August 14, 2025

Musk Sues Altman Over OpenAI Mission Betrayal

Elon Musk is suing Sam Altman over allegations that he diverted OpenAI from its non-profit mission. Despite the legal dispute, both tech leaders are moving forward with new projects, including Neuralink and xAI for Musk, and Merge Labs for Altman.


August 14, 2025

Neuralink Raises $650 Million for Brain-Chip Tech

Neuralink has made significant progress in brain-computer interface (BCI) technology, having implanted chips into eight patients in the US, including Audrey Crews, who was paralyzed since age 16. The company recently raised $650 million, valuing it at $9 billion, while rival firm Merge Labs is seeking $250 million for its own BCI project. Both Elon Musk and Sam Altman aim to develop a "general population device" that enables humans and computers to merge, with Altman predicting this will happen between 2025 and 2075.


August 14, 2025

Nvidia Defies Tariffs with AI Ambitions Ahead

Nvidia's stock price is not a major concern for investors who are optimistic about the company's potential in the AI sector, despite US President Donald Trump imposing a 15% tariff on Nvidia's Chinese-made graphics processing units (GPUs). The tariffs may increase production costs, but Nvidia's focus on developing its own GPUs and expanding into new markets could mitigate this impact.


August 14, 2025

Nvidia Unveils RTX Pro 4000 SFF Workstation GPUs

Nvidia is launching new workstation GPUs, the RTX Pro 4000 SFF and RTX Pro 2000, which share the Blackwell architecture benefits of its larger RTX PRO lineup. These smaller GPUs are expected to provide a large performance increase over earlier small-format workstations while keeping power consumption in check. They will be available through partners such as PNY, TD Synnex, Dell, HP, and Lenovo later this year, with prices not yet disclosed. The new GPUs are marketed as an upgrade path for professionals, particularly for tasks that benefit heavily from GPU compute, such as AI inference, large-scale rendering, and simulation.


August 14, 2025

Oracle Cuts Cloud Division Jobs Amid AI Investments

Oracle Corp. is cutting jobs in its cloud division as it attempts to control costs amid significant investments in artificial intelligence (AI) infrastructure. The company has been heavily spending on AI, and this move comes as a result of efforts to manage expenses. Impacted workers were informed that their roles have been eliminated.


August 14, 2025

Oracle Teams with Alphabet on Gemini AI Integration

Oracle and Alphabet have partnered to offer Google's Gemini artificial intelligence models through Oracle's cloud computing services, allowing software developers to generate text, video, images, and audio using the technology. This deal enables businesses that use Oracle's applications for corporate finances, human resources, and supply chain planning to integrate Google's AI models into their existing systems, with payments processed through Oracle's cloud credits system.


August 14, 2025

Parag Agrawal Launches New AI Venture Ironfish

Parag Agrawal, the former CEO of Twitter, has started an AI company called Ironfish, following a tumultuous period after taking over as CEO from Elon Musk in October 2022.


August 14, 2025

Penn Medicine's AI Cancer Cell Detector Unveiled

Artificial intelligence is revolutionizing cancer research and treatment through its ability to process vast medical knowledge, identify risk factors, aid in early diagnosis, and accelerate drug discovery. A recent breakthrough at Penn Medicine has developed a tool that can detect cancer cells invisible to the human eye, while an AI system has been shown to predict pancreatic cancer with accuracy rivaling expensive genetic tests.